|1.||Fontana, Giovanni A: 1 article (08/2015)|
|2.||Campi, Giacomo: 1 article (08/2015)|
|3.||Mannini, Claudia: 1 article (08/2015)|
|4.||Chellini, Elisa: 1 article (08/2015)|
|5.||Lavorini, Federico: 1 article (08/2015)|
|6.||Kaito, Daizo: 1 article (01/2015)|
|7.||Itoh, Yoshinori: 1 article (01/2015)|
|8.||Tanaka, Hidekazu: 1 article (01/2015)|
|9.||Ohno, Yasushi: 1 article (01/2015)|
|10.||Ito, Fumitaka: 1 article (01/2015)|
|1.||Duodenal Ulcer (Curling's Ulcer)
09/01/1991 - "Thus, it can be concluded that low-dose AA-treatment using an aluminum/magnesium hydroxide preparation in tablet form represents an effective and safe therapy for duodenal ulcer."
01/01/1991 - "One hundred outpatients with endoscopically verified duodenal ulcer were treated in a double-blind, randomized, multicenter trial with either low-dose antacid (AA, Supralox, 1 tablet three times a day 1 h a.c. "
08/01/1987 - "Clinical investigations have shown that antacid mixtures of aluminum-magnesium hydroxide healed gastric an duodenal ulcers (neutralizing capacity 100-150 mmol/day) as well as H2 receptor antagonists and better than a placebo. "
11/01/1986 - "The aim of the present investigation was to compare the efficacy of a low-dose antacid (Maalox 70, 280 mmol/day) with that of the H2-receptor antagonist cimetidine (Tagamet, 200 mg three times daily and 400 mg/day) after 14 and 28 days in the treatment of duodenal ulcer. "
01/01/1994 - "Antacid properties of Maalox were studied versus those of Almagel in 24 duodenal ulcer patients by the following indices of pH-metry: time of pH response onset, "alkaline time", alkalification area and index. "
|2.||Stomach Ulcer (Gastric Ulcer)
01/01/1994 - "Regular Maalox intake as a main medicine provided good results in the treatment of duodenal ulcer (25 responders), gastric ulcer (14 responders), erosive gastroduodenitis (14 responders), erosive reflux-esophagitis (9 responders). "
01/13/1979 - "A bismuth-peptide complex (BCP Compound), an antacid (Maalox) and corresponding placebos were studied in a 6-week comparative double-blind trial of treatment in 106 randomized ambulant patients with endoscopically proven duodenal and gastric ulcers. "
01/01/1990 - "We showed that 10 days' treatment with high-dose antacids (Maalox TC) is able to increase 6-keto-PGF1 alpha production from cultured biopsy specimens of patients with gastric ulcer. "
08/01/1978 - "The effect of Mucaine and Aludrox on basal and food stimulated immunoreactive gastrin has been assessed in normal control subjects and patients with duodenal or gastric ulcer. "
07/01/1983 - "In view of contradictory reports on the bioavailability of cimetidine in the presence of concomitantly administered antacids we studied the areas under the plasma concentration time curves (AUC) of cimetidine, the maximal concentrations (cmax) and the time, at which cmax was reached (tmax) in eight patients (five patients with duodenal ulcer, three patients with gastric ulcer) with and without the administration of an aluminum hydroxide magnesium hydroxide containing antacid (Maaloxan). "
07/19/1986 - "At intervals, Alucol liquid was given for stress ulcer prevention through the tube. "
09/01/1990 - "Removal of salivary glands, the major source of EGF, also prolonged ulcer healing but, again, Maalox was as effective in ulcer healing as in rats with intact salivary glands. "
08/08/1991 - "Ulcer healing with sucralfate resulted in significant (p less than 0.05) decreases in low-dose acid output from 36.4% (13.2-51.0) (median [range]) to 8.4% (3.2-45.4) mmol/hour and PCS from 69.1% (44.9-91.4) to 22.0% (16.0-85.6), whereas no significant decreases in any of the measured parameters were noted following ulcer healing with Maalox. "
07/01/1991 - "Per protocol analysis in 53 patients showed ulcer healing rates at week 4 and at weeks 4 and 6 combined of 78 and 89% on Maalox TC, and of 81 and 91% on ranitidine, respectively. "
01/01/1983 - "Oral Maalox (antacid) at 1,000 mg/kg thrice daily and propantheline (anticholinergic agent) at 30 mg/kg twice daily tended to accelerate the healing of the ulcers. "
05/01/1999 - "The bladder hemorrhage had not completely disappeared but improved 5 days after the bladder irrigation of 100 ml of Maalox with 100 ml of 0.9% NaCl for an hour per day. "
05/01/1999 - "In the first case, bladder hemorrhage had decreased 4 days after the intravesical instillation of 50-100 ml Maalox for an hour per day. "
05/01/1999 - "Two cases treated by intravesical instillation of Maalox for bladder hemorrhage are reported. "
02/01/2001 - "Usefulness of Maalox for detection of the precise bleeding points and confirmation of hemostasis on gastrointestinal hemorrhage."
03/01/1995 - "A premature infant with severe enteroviral infection was treated with Maalox for gastric bleeding. "
|5.||Peptic Ulcer (Peptic Ulcers)
10/01/1954 - "Magnesium aluminum hydroxide gel in the antacid therapy of peptic ulcer."
05/15/1996 - "To assess the effect of aluminum hydroxide/magnesium hydroxide antacid and bismuth subsalicylate on gastric pH in clinically normal horses and to develop guidelines on the use of these agents for treatment of peptic ulcer disease in horses. "
07/01/1983 - "Absence of in vivo and in vitro interactions of an aluminum hydroxide, magnesium hydroxide containing antacid with cimetidine in patients with peptic ulcer."
07/01/1999 - "Co-magaldrox (Maalox) is used world-wide as an antacid and as a cytoprotective agent for gastritis and peptic ulcer diseases. "
01/01/1987 - "Sucralfate, one of the newer drugs shown to be effective in the treatment of peptic ulcer and esophagitis; cholestyramine, a known bile acid binder; and commercial antacid preparations of pure aluminum hydroxide, pure magnesium hydroxide, and a combination of aluminum hydroxide, magnesium hydroxide, and magnesium carbonate were tested in vitro for bile acid-binding capacity. "
|1.||Cholestyramine Resin (Questran)
|5.||Magnesium Hydroxide (Brucite)
|10.||Calcium Carbonate (Limestone)
|4.||Intensive Care (Surgical Intensive Care)